Opaleye Management Inc. has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $508 Million distributed in 39 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Harrow Health, Inc. with a value of $134M, Tg Therapeutics, Inc. with a value of $68M, Codexis, Inc. with a value of $42.2M, Eton Pharmaceuticals, Inc. with a value of $37.5M, and Ocular Therapeutix, Inc with a value of $37.1M.

Examining the 13F form we can see an decrease of $39.4M in the current position value, from $548M to 508M.

Opaleye Management Inc. is based out at Boston, MA

Below you can find more details about Opaleye Management Inc. portfolio as well as his latest detailed transactions.

Portfolio value $508 Million
Healthcare: $508 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 39
  • Current Value $508 Million
  • Prior Value $548 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 6 stocks
  • Additional Purchases 13 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.